These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 5165600

  • 21. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours.
    Pavone-Macaluso M, Caramia G, Rizzo FP.
    Urol Int; 1971; 26(5):379-87. PubMed ID: 5136749
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Current trends in bladder cancer treatment.
    Lamm DL, Allaway M.
    Ann Chir Gynaecol; 2000; 89(3):234-41. PubMed ID: 11079794
    [No Abstract] [Full Text] [Related]

  • 25. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S, Akaza H, Ohashi Y, Kotake T.
    Cancer; 1999 Nov 01; 86(9):1818-26. PubMed ID: 10547556
    [Abstract] [Full Text] [Related]

  • 26. Urinary bladder cancer: mechanisms of development and progression.
    Kroft SH, Oyasu R.
    Lab Invest; 1994 Aug 01; 71(2):158-74. PubMed ID: 8078295
    [No Abstract] [Full Text] [Related]

  • 27. Intravesical chemotherapy--other agents.
    Smith PH, Cruickshank J, Hetherington JW.
    Prog Clin Biol Res; 1984 Aug 01; 162B():173-9. PubMed ID: 6504895
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of the efficacy of oral methotrexate in the prophylaxis of recurrences of superficial tumors of the bladder].
    Nogueira March JL, Ojea A, Figueiredo L, Jamardo D, Diez E, Pérez-Villanueva J.
    Actas Urol Esp; 1984 Aug 01; 8(5):391-4. PubMed ID: 6524485
    [No Abstract] [Full Text] [Related]

  • 29. [Development of bladder cancer chemoprevention].
    Dai G, Wang X.
    Wei Sheng Yan Jiu; 2003 Mar 01; 32(2):159-62. PubMed ID: 12793013
    [Abstract] [Full Text] [Related]

  • 30. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Mar 01; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 31. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR, Kopp J.
    Prog Clin Biol Res; 1984 Mar 01; 162B():397-427. PubMed ID: 6438644
    [No Abstract] [Full Text] [Related]

  • 32. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
    Ayres BE, Crew JP, Action for Bladder Cancer.
    BJU Int; 2010 Feb 01; 105 Suppl 2():14-7. PubMed ID: 20089093
    [No Abstract] [Full Text] [Related]

  • 33. Vitamin A and tumor recurrence in bladder cancer.
    Michalek AM, Cummings KM, Phelan J.
    Nutr Cancer; 1987 Feb 01; 9(2-3):143-6. PubMed ID: 3562292
    [Abstract] [Full Text] [Related]

  • 34. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
    Jakse G.
    Prog Clin Biol Res; 1985 Feb 01; 185B():69-78. PubMed ID: 3898142
    [No Abstract] [Full Text] [Related]

  • 35. [Tumor recurrence prevention using photodynamic therapy after treatment of bladder cancer].
    Sun X, Li H, Wang M.
    Zhonghua Wai Ke Za Zhi; 1995 Mar 01; 33(3):179-80. PubMed ID: 7555391
    [Abstract] [Full Text] [Related]

  • 36. [A randomized controlled study to compare bladder instillation therapy of anticancer agents and combination therapy with OK-432 injection in prevention of post-TUR recurrence of bladder cancer].
    Nishio S, Yoshihara H, Yamamoto K, Kishimoto T, Maekawa M.
    Hinyokika Kiyo; 1988 Nov 01; 34(11):2053-7. PubMed ID: 2468266
    [Abstract] [Full Text] [Related]

  • 37. Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
    Gee JR, Jarrard DF, Bruskewitz RC, Moon TD, Hedican SP, Leverson GE, Nakada SY, Messing EM.
    BJU Int; 2009 Mar 01; 103(6):736-9. PubMed ID: 19007364
    [Abstract] [Full Text] [Related]

  • 38. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q, Xu T, Wang XF.
    Zhonghua Zhong Liu Za Zhi; 2009 Dec 01; 31(12):904-7. PubMed ID: 20193328
    [Abstract] [Full Text] [Related]

  • 39. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W.
    Nat Clin Pract Urol; 2006 Nov 01; 3(11):582-3. PubMed ID: 17088923
    [No Abstract] [Full Text] [Related]

  • 40. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
    Imamoğlu MA, Bakirtaş H, Yiğitbaşi O, Ersoy H, Sertçelik AN.
    Arch Esp Urol; 2001 Dec 01; 54(10):1147-53. PubMed ID: 11852530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.